Blueprint Medicines - on May 22, After Exceeding Milestone From Sales of Ayvakit, Lenders Funded Tranche B Delayed Draw Term Loan of $150.0 Mln
Blueprint Medicines——在Ayvakit的銷售額超過里程碑之後,貸款機構於5月22日資助了B批延期提取1.50億美元的定期貸款
Blueprint Medicines - on May 22, After Exceeding Milestone From Sales of Ayvakit, Lenders Funded Tranche B Delayed Draw Term Loan of $150.0 Mln
Blueprint Medicines——在Ayvakit的銷售額超過里程碑之後,貸款機構於5月22日資助了B批延期提取1.50億美元的定期貸款
譯文內容由第三人軟體翻譯。